Ami Organics Ltd
P&L
Quarterly Consolidated
vs Q2 FY26
Acutaas Chemicals Q3 FY26 Results: Revenue at INR 3,932mn, PAT Crosses INR 1,000mn
28 Jan 2026 · 28 Jan, 3:17 pm
Summary
Acutaas Chemicals Limited, a leading global manufacturer of advance pharmaceutical intermediates and speciality chemicals, announced financial results for the quarter and nine months ended December 31, 2025. The company reported a 43.0% YoY increase in revenue from operations and a 133.7% YoY increase in PAT.
Key Highlights
- 1
Revenue from Operations for Q3FY26 grew by 43.0% YoY to Rs. 3,932 mn
- 2
Gross margin for the quarter improved to 57.0%
- 3
EBITDA for the quarter came at Rs. 1,507 mn up 119.4% YoY
- 4
PAT for the quarter was Rs. 1,062 mn up 133.7% as compared to PAT of Rs. 454 mn in Q3FY25
- 5
The company is expanding its portfolio to include high-value speciality chemicals for emerging technologies such as battery materials, semiconductor, and next-generation electronic applications
Management Comments
Mr. Naresh Patel
We continue to reinforce our core pharmaceutical intermediates business through the addition of CMO/CDMO opportunities alongside strengthening our business foundation by scaling battery chemicals and semiconductor chemicals verticals. These businesses, which are currently under active capital investment, are progressing steadily toward scale. Over the next three years, we expect each vertical to operate as an independent, self-sustaining growth engine, contributing meaningfully to our overall topline.
Informational and educational content only. Not investment advice.